Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
Hyo‐Jeong Lee(Seoul National University), Sun‐Young Han(Gyeongsang National University)
Cited by 15
Related Papers
Oral administration of penta-O-galloyl- -D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition
|Carcinogenesis|2011|80
Differential Gene Regulation by Specific Gain-of-function JNK1 Proteins Expressed in Swiss 3T3 Fibroblasts
|Journal of Biological Chemistry|2002|48
Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects
|International Journal of Oncology|2013|36
Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia
|European Journal of Medicinal Chemistry|2020|29
Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma
|Clinical and Molecular Hepatology|2015|27